Enzymatic activation of benzothiophenes for enantioselective metal-free cross-coupling
Enzymatic activation of benzothiophenes for enantioselective metal-free cross-coupling
批准号:
2752683
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In the future, high-value molecules must be prepared efficiently without the use of expensive, toxic and supply-risk metal catalysts. Furthermore, efficient control of the 3D shape of products ('enantiocontrol') is crucial as medicines, for example, become richer in stereochemical information. Decorated benzothiophenes enjoy a privileged status as a motif found in new medicines and agrochemicals and in reagents for synthesis. However, methods for their preparation often require unsustainable procedures. To address this challenge, we have recently learned to exploit benzothiophene S-oxides as intermediates in metal-free approaches to decorated benzothiophenes and also as reagents for metal-free synthesis mediated by light Crucially, our studies, and the work of others, has involved racemic benzothiophene S-oxides and enantioselective processes exploiting stereochemistry at sulfur are therefore not possible.We propose that state-of-the-art enzymatic oxidation will allow access to benzothiophene S-oxides in enantioenriched form, thus allowing - for the first time - their use in enantioselective metal-free cross-coupling procedures for the sustainable construction of high-value products for industrial exploitation. The Green group's expertise in biocatalysis will allow scarce literature precedent for the enzymatic oxidation of benzothiophenes to enantioenriched S-oxides using oxygenases to be developed into general, scalable biocatalytic processes. The enantioenriched S-oxides will then be leveraged in two ways (building upon Procter group technology); firstly, they will be converted, via versatile intermediates, into stereochemically-rich products through a three-component coupling/dearomatisation sequence. Secondly, they will be used as recyclable activators of substrates, such as alkynes, to give enantioenriched sulfonium salts 8 for use in enantioselective metal free cross-couplings with prochiral nucleophiles.Our approach will integrate bio/chemo catalysis to deliver stereodefined, complex benzothiophenes and small fragment scaffolds that are either currently unavailable or cannot be prepared without recourse to the use of expensive, toxic and supply-risk metal catalysts (and expensive chiral ligands). The overarching project aims will be underpinned by several research outcomes; i) the development of new biocatalytic oxidations; ii) an improved understanding of the chemistry of benzothiophene S-oxides and their configurational stability, and; iii) computational mechanistic studies aimed at understanding the origin of selectivity in enzymatic S-oxidation. With crucial support in computational chemistry, leaders in metal-free couplings and biocatalysis will join forces for the first time and pool their complementary expertise. The student will receive a unique training: biocatalysis (Green) and organosulfur chemistry (Procter).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
-
批准号:82371103
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮静
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位:
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
-
批准号:82371223
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:闻大翔
-
依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
基于CRISPR Activation转录激活系统的籼稻新型再生因子的挖掘
-
批准号:32301275
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈璐
-
依托单位:
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
-
批准号:82372202
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯旭敏
-
依托单位:
cGAS-STING通路调控单核细胞活化参与Graves病发病的机制研究
-
批准号:82370787
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王曙
-
依托单位:
SOD1介导星形胶质细胞活化调控hNSC移植细胞存活的机制研究
-
批准号:82372136
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:付雪梅
-
依托单位:
TXNIP调控实验性青光眼视乳头星形胶质细胞的激活及其机制研究
-
批准号:82371048
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:钟一声
-
依托单位:
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
-
批准号:82372327
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:马展
-
依托单位: